David W. Borhani
12Patents
6h-index
33Co-inventors
62Inventor score
Filing activity: Aug 5, 2002 → Oct 17, 2016
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8008481B2 | Indazole compounds | Chemistry; Metallurgy | 107 | Active |
| US8034906B2 | Crystalline anti-hTNFalpha antibodies | Chemistry; Metallurgy | 78 | Active |
| US8436149B2 | Crystalline anti-hTNFalpha antibodies | Chemistry; Metallurgy | 69 | Active |
| US7790741B2 | Imidazothiazoles and imidazoxazoles | Chemistry; Metallurgy | 19 | Active |
| US8753839B2 | Compositions and methods for crystallizing antibodies | Emerging Cross-Sectional Technologies | 16 | Active |
| US8168760B2 | Crystalline anti-human IL-12 antibodies | Emerging Cross-Sectional Technologies | 12 | Active |
| US8404819B2 | Crystalline anti-human IL-12 antibodies | Emerging Cross-Sectional Technologies | 2 | Active |
| US7400979B2 | Method of identifying inhibitors of Lck | Chemistry; Metallurgy | 1 | Expired |
| US8772458B2 | Crystalline anti-hTNFalpha antibodies | Chemistry; Metallurgy | 1 | Active |
| US10753947B2 | Methods for screening voltage-gated proteins | Physics | 0 | Active |
| US10739354B2 | Methods for screening voltage-gated proteins | Physics | 0 | Active |
| US8940873B2 | Crystalline anti-human IL-12 antibodies | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.